Drugs / NB1011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00248404 | Sep 2005 → Dec 2007 | neoplasm | Kiadis Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NB1011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00248404 ↗ |
| Route | Intravenous | “Administered Intravenously by Continuous Infusion” NCT00248404 ↗ |